Abstract

Cancer treatment with a combination of an Epidermal Growth Factor Receptor tyrosine kinase inhibitor and an Interleukin-6 inhibitor.


Claims
Download PDF
Document Preview
Document History
  • Publication: Dec 4, 2012
  • Application: Oct 12, 2010
    US US 90313310 A
  • Priority: Oct 12, 2010
    US US 90313310 A
  • Priority: Oct 9, 2009
    US US 25029109 P

Download Citation


Sign in to the Lens

Feedback